Company / Depreciation & Amortization
Prime Medicine, Inc. Depreciation & Amortization History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$6.1M
FY2024
5-year range
$43.0K / $6.1M
FY2020-FY2024
Trend
+31.7%
vs FY2023
Sector context
#82 of 192
Health Care
What the data says
At $6M, Prime Medicine, Inc.'s depreciation & amortization ranks #111 of 192 in the Health Care sector. Depreciation & Amortization has increased for 4 consecutive years, from $43,000 in FY2020 to $6M in FY2024.
Based on SEC 10-K filings.
$6M in FY2024 with a 3-year CAGR of +121.0%.
Increased from $2M to $6M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +121.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#111 of 192 in Health CareTop 57% of 192This company $6.1M Sector average $188.2M
▼
-96.7% below sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 3-year CAGR of +121.0%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 31.7% year-over-year.
- Ranks #82 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.1M | +31.7% |
| FY2023 | $4.7M | +109.2% |
| FY2022 | $2.2M | +291.5% |
| FY2021 | $568.0K | +1220.9% |
| FY2020 | $43.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026